Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN III 10 versus NUTRILIPID 10.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN III 10 versus NUTRILIPID 10.
LIPOSYN III 10% vs NUTRILIPID 10%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Liposyn III 10% is an intravenous fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of calories. The triglycerides are hydrolyzed by lipoprotein lipase to free fatty acids and glycerol, which are then utilized for energy production or stored. The emulsion particles are metabolized similarly to endogenous chylomicrons.
Nutrilipid 10% is a fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of calories. It serves as a component of parenteral nutrition, supplying triglycerides that are metabolized to free fatty acids and glycerol for energy production and cellular functions.
Intravenous infusion: 500 mL to 1000 mL per day, providing 10% lipid emulsion (100 g fat per liter), infused over 8-12 hours as part of parenteral nutrition, not to exceed 2.5 g fat/kg/day.
Intravenous infusion, 1-2 g/kg/day (0.5-1 g/kg/day for 10% emulsion), not to exceed 2.5 g/kg/day. Initial rate 0.5-1 mL/min for first 15-30 minutes, then increase to maximum of 125 mL/hour.
None Documented
None Documented
Triglycerides in Liposyn III 10% have a terminal elimination half-life of approximately 0.5 to 1 hour in patients with normal lipid metabolism. In neonates or hepatic impairment, half-life may be prolonged.
Terminal elimination half-life: approximately 0.5-1 hour for the triglyceride component in healthy adults; clinically, clearance depends on infusion rate and metabolic capacity, with prolonged half-life in hypertriglyceridemia.
Lipids are metabolized via hydrolysis by lipoprotein lipase into free fatty acids and glycerol. Free fatty acids undergo beta-oxidation or re-esterification. Elimination of CO2 via lungs; less than 5% excreted renally as glycerol and other metabolites.
Renal: negligible; biliary/fecal: not applicable as lipid emulsion is metabolized; elimination primarily via lipoprotein lipase-mediated clearance from plasma.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion